EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment

Yang Liu, Lin Cui, Xiao Wang, Weiling Miao, Yongxu Ju, Tiandong Chen, Huiting Xu, Ning Gu, Fang Yang iD

Advanced Science · 2023

DOI: 10.1002/advs.202300679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Yang Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences and Medical Engineering, S…. Hauptthemen laut MEDLINE: Glioma, Glioblastoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Universal chemotherapy in glioblastoma patients causes chemoresistance and further limits immune cells by creating an immunosuppressive tumor microenvironment that are difficult to solve by single‐drug therapeutic approaches. Here, this work designs hybrid drug‐loaded nanoliposomes by co‐loading the chemotherapeutic drug temozolomide (TMZ) and nitric oxide (NO) prodrug JS‐K with sphingosine‐1‐phosphate molecules (S1P) on the surface. The S1P‐S1P receptors axis endows nanoliposomes with rapid targeting and lysosomal escaping capability. Then, fine‐tuned TMZ release and NO gas production following JS‐K release in glioma microenvironment decrease chemoresistance and increase tumor immunogenicity through inhibiting the cellular autophagy as well as inducing mitochondrial dysfunction. RNA sequencing analysis demonstrates that the NO gas generation reprograms glioma microenvironment immune and inflammation‐related pathways. The positive immune response in turn effectively activates the enhanced efficacy of chemotherapy. NO gas generated nanoliposomes thus have attractive paradigm‐shifting applications in the treatment of “cold” tumors across a range of immunosuppressive indications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaGlioblastomaHumansNitric OxideCell Line, TumorTemozolomideImmunosuppressive AgentsTumor Microenvironment

Stichwörter der Autor:innen

autophagy inhibitionchemoimmunotherapyglioblastoma therapyimmunogenic deathnitric oxide

Substanzen

Nitric OxideTemozolomideImmunosuppressive Agents

Autor:innen und Institutionen

  • State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences and Medical Engineering, Southeast University, Nanjing, 210096, P. R. China.

ORCID-Profile: Fang Yang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Jiangsu Excellent Postdoctoral Program
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Liu, Y., Cui, L., Wang, X., Miao, W., Ju, Y., Chen, T., Xu, H., Gu, N., & Yang, F. (2023). In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment. Advanced Science. https://doi.org/10.1002/advs.202300679

Vancouver

Liu Y, Cui L, Wang X, Miao W, Ju Y, Chen T, et al. In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment. Advanced Science. 2023. doi:10.1002/advs.202300679

BibTeX
@article{Liu2023,
  author = {Liu, Yang and Cui, Lin and Wang, Xiao and Miao, Weiling and Ju, Yongxu and Chen, Tiandong and Xu, Huiting and Gu, Ning and Yang, Fang},
  title = {In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment},
  journal = {Advanced Science},
  year = {2023},
  doi = {10.1002/advs.202300679}
}
Kostenlos starten →